✦ LIBER ✦

P1-060 Education and rates of cognitive decline in incident Alzheimer's disease (AD)

✍ Scribed by Nikolaos Scarmeas; Steven M. Albert; Jennifer Manly; Yaakov Stern

Book ID: 117412940
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 310 KB
Volume: 25
Category: Article
ISSN: 0197-4580
DOI: 10.1016/s0197-4580(04)80374-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cognitive decline and mortality in Alzhe

Cognitive decline and mortality in Alzheimer's disease (AD)

✍ Willmott, Andrew J. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 151 KB

P1-240: Three year cognitive decline of

P1-240: Three year cognitive decline of Alzheimer’s disease: Influence of education

✍ Minyoung Shin; Ji-Hae Kim 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

P1-074 Cognitive decline with preservati

P1-074 Cognitive decline with preservation of creativity in Alzheimer's disease

✍ Dielle Miranda; Nina Apanasiewicz; Luis R. Fornazzari; Alexandra Salvarrey; Shai 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Assessing rates of cognitive decline in

Assessing rates of cognitive decline in Alzheimer's disease and dementia with Lewy bodies

✍ Ard, M. Colin; Galasko, Douglas; Salmon, David; Edland, Steven 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 51 KB

PSEN1 polymorphisms alter the rate of co

PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients

✍ Olivia Belbin; Helen Beaumont; Donald Warden; A. David Smith; Noor Kalsheker; Ke 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 311 KB

A longitudinal study of Alzheimer's dise

A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline

✍ Guk-Hee Suh; Young-Su Ju; Byeong Kil Yeon; Ajit Shah 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## Abstract ## Objective To measure rates of decline in cognition and function in patients with Alzheimer's disease (AD) and to investigate their accelerating risk factors in Korea. ## Methods This study presents longitudinal data on a community‐based sample of 107 patients with AD, followed at